Bioceres Crop Solutions (NASDAQ:BIOX) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen downgraded shares of Bioceres Crop Solutions (NASDAQ:BIOXFree Report) from a hold rating to a sell rating in a research report report published on Saturday morning.

Separately, Oppenheimer cut their target price on Bioceres Crop Solutions from $7.00 to $6.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 15th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Bioceres Crop Solutions currently has a consensus rating of “Moderate Buy” and an average price target of $8.38.

Read Our Latest Analysis on BIOX

Bioceres Crop Solutions Stock Performance

Shares of BIOX opened at $2.79 on Friday. The business’s fifty day simple moving average is $3.84 and its two-hundred day simple moving average is $4.29. The company has a current ratio of 1.02, a quick ratio of 0.74 and a debt-to-equity ratio of 0.22. Bioceres Crop Solutions has a 12 month low of $2.60 and a 12 month high of $11.41. The company has a market cap of $174.96 million, a price-to-earnings ratio of -19.93, a P/E/G ratio of 1.25 and a beta of 0.44.

Institutional Trading of Bioceres Crop Solutions

Large investors have recently modified their holdings of the company. Jones Financial Companies Lllp grew its holdings in shares of Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after acquiring an additional 5,339 shares during the period. Bank of America Corp DE grew its holdings in shares of Bioceres Crop Solutions by 186.8% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after acquiring an additional 3,735 shares during the period. Jump Financial LLC bought a new stake in shares of Bioceres Crop Solutions in the fourth quarter worth $72,000. Avanza Fonder AB bought a new stake in shares of Bioceres Crop Solutions in the first quarter worth $72,000. Finally, PDT Partners LLC bought a new stake in shares of Bioceres Crop Solutions in the first quarter worth $81,000. Institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Further Reading

Analyst Recommendations for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.